CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN
Hepatitis A — the most widespread virus disease of the liver in human. In the general structure of virus hepatitis no less than 90% makes hepatitis A. Hepatitis A is usually a self' limiting disease and infection confers lifelong immunity. However, the hepatitis A has of great clinical importan...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2009-06-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/910 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849394089296920576 |
|---|---|
| author | V.F. Uchaikin T.V. Cherednichenko O.B. Kovalev |
| author_facet | V.F. Uchaikin T.V. Cherednichenko O.B. Kovalev |
| author_sort | V.F. Uchaikin |
| collection | DOAJ |
| description | Hepatitis A — the most widespread virus disease of the liver in human. In the general structure of virus hepatitis no less than 90% makes hepatitis A. Hepatitis A is usually a self' limiting disease and infection confers lifelong immunity. However, the hepatitis A has of great clinical importance in children. Hepatitis A virus causes both acute disease and asymptomatic infection. The disease is usually asymptomatic in young children. Acute hepatitis A usually lead to full liver recovery during 2–3 months or protracted hepatitis A — a condition in which the virus is slow to clear and the liver takes longer than usual to regain its normal function and can last for up to 5–6 weeks. Hepatitis A does not cause chronic infection, but can lead to some complications. From 1158 children treated for hepatitis A in our clinic, 85,7% has developed affection biliary tracts, 76,7% — affection duodenum, 4,5% — was registered residual liver fibrosis. So, Hepatitis A is a serious disease and can lead to considerable clinical and economical burden. Introduction the mass vaccination programme in Russia will lead to decrease incidence, long'term effects and complications of Hepatitis A in children.Key words: hepatitis A, children, outcomes, burden, vaccination programme. |
| format | Article |
| id | doaj-art-0c8384114d5d45fd8897a3074e32ea19 |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2009-06-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-0c8384114d5d45fd8897a3074e32ea192025-08-20T03:40:11ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892009-06-0163712905CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDRENV.F. Uchaikin0T.V. Cherednichenko1O.B. Kovalev2Russian State Medical University, MoscowRussian State Medical University, MoscowRussian State Medical University, MoscowHepatitis A — the most widespread virus disease of the liver in human. In the general structure of virus hepatitis no less than 90% makes hepatitis A. Hepatitis A is usually a self' limiting disease and infection confers lifelong immunity. However, the hepatitis A has of great clinical importance in children. Hepatitis A virus causes both acute disease and asymptomatic infection. The disease is usually asymptomatic in young children. Acute hepatitis A usually lead to full liver recovery during 2–3 months or protracted hepatitis A — a condition in which the virus is slow to clear and the liver takes longer than usual to regain its normal function and can last for up to 5–6 weeks. Hepatitis A does not cause chronic infection, but can lead to some complications. From 1158 children treated for hepatitis A in our clinic, 85,7% has developed affection biliary tracts, 76,7% — affection duodenum, 4,5% — was registered residual liver fibrosis. So, Hepatitis A is a serious disease and can lead to considerable clinical and economical burden. Introduction the mass vaccination programme in Russia will lead to decrease incidence, long'term effects and complications of Hepatitis A in children.Key words: hepatitis A, children, outcomes, burden, vaccination programme.https://www.pedpharma.ru/jour/article/view/910 |
| spellingShingle | V.F. Uchaikin T.V. Cherednichenko O.B. Kovalev CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN Педиатрическая фармакология |
| title | CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN |
| title_full | CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN |
| title_fullStr | CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN |
| title_full_unstemmed | CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN |
| title_short | CLINICAL COURSE, LONG–TERM EFFECTS AND OUTCOMES HEPATITIS A IN CHILDREN |
| title_sort | clinical course long term effects and outcomes hepatitis a in children |
| url | https://www.pedpharma.ru/jour/article/view/910 |
| work_keys_str_mv | AT vfuchaikin clinicalcourselongtermeffectsandoutcomeshepatitisainchildren AT tvcherednichenko clinicalcourselongtermeffectsandoutcomeshepatitisainchildren AT obkovalev clinicalcourselongtermeffectsandoutcomeshepatitisainchildren |